These data confirm the crucial role of ZEB2 in the regulation of tumour invasion and are in line with the involvement of the HIF-1–ZEB2–ephrinB2 axis in the increased invasiveness following bevacizumab treatment. The gene discussed is ZEB2; the disease is neoplasm.